Retatrutide
A triple agonist (GIP/GLP-1/Glucagon) in clinical trials showing exceptional weight loss results.
People use this for
Benefit Profile
Retatrutide's fingerprint across categories
Community Interest
Report volume over 12 months
Reported Benefits
1 of 1Exceptional Weight Loss
Strongly Positive"Clinical trial results are insane - up to 24% body weight loss. This could be the biggest yet."
Reported Side Effects
Nausea, diarrhea, constipation common.
Dosing Patterns
Most Popular: SubQ at Up to 12 mg
90% of community members report using this dosing protocol 1x weekly. Individual responses vary — start low and adjust based on your experience.
Where to Buy
Trusted vendors recommended by the community. We may receive a commission from purchases.
Peptide Sciences
USA-based, 3rd party tested, COA provided
Swiss Chems
European quality standards, bulk discounts
Amino Asylum
Competitive pricing, fast US shipping
Limitless Life
Premium quality, pharmaceutical grade
Disclaimer: DYK Peptides may receive affiliate commissions from purchases made through these links. This does not affect our editorial integrity or the recommendations we provide. Peptides are sold for research purposes only and are not intended for human consumption. Always consult with a healthcare professional before using any research compounds.
Commonly Stacked With
Frequently Asked
Retatrutide is a triple hormone receptor agonist in development for obesity and diabetes.